RGT
Pharmaceuticals, Biotechnology & Life Sciences
Argent Biopharma
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 19 Aug 2024
- Reported shorts
- 1
- Shares on issue
- 48.406M
Argent Biopharma (RGT) company profile
Profile, insiders and operations
Company
AI-generated research profile of Argent Biopharma
biotechnology
pharmaceutical development
plant-based medicine
unmet medical needs
european pharmaceuticals
Argent Biopharma Limited is a European-based pharmaceuticals company that focuses on creating innovative plant-inspired medicines and treatments addressing unmet medical conditions. The firm leverages its unique expertise in extracting and processing natural compounds to produce pharmaceuticals that serve niche, underserved markets. With a strong research and development emphasis, Argent positions itself as a leader in naturally-derived pharmaceutical solutions, aiming to enhance treatment efficacy and patient safety.
Director trades
12 trades recorded
RGT intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required